| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Revenue | $1.3B | $1.2B | $0.9B |
| Cost of Revenue | — | — | — |
| Gross Profit | — | — | $0.3B |
| R&D Expense | — | — | — |
| SG&A Expense | $0.1B | $0.2B | $0.1B |
| Operating Income | $0.3B | $0.2B | $0.2B |
| Net Income | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $0.90 | $0.58 | $0.29 |
| EPS (Diluted) | $0.89 | $0.56 | $0.29 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Total Assets | $4.3B | $4.4B | $3.2B |
| Current Assets | $0.3B | $0.4B | $0.2B |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $3.1B | $3.1B | $2.1B |
| Current Liabilities | $0.4B | $0.3B | $0.2B |
| Stockholders' Equity | — | — | $1.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.3B | $0.3B |
| Investing Cash Flow | $-0.3B | $-0.3B | $-0.2B |
| Capital Expenditures | $0.3B | $0.3B | $0.2B |
| Financing Cash Flow | $-0.3B | $-0.0B | $-0.1B |